India complains to Beijing over treatment of diplomat
NEW DELHI (Reuters) - China has agreed to look into a complaint by India's foreign ministry that a diplomat was prevented from treating his severe diabetes and collapsed while offering consular assistance to two Indian citizens on trial in China's Yiwu city.
S. Balachandran from the Indian consulate in Shanghai, had to be hospitalised after attending a court hearing that lasted five hours without being able to treat his condition, said an Indian government source who declined to be named.
"We have taken it up pretty strongly with the Chinese, that this is no way to treat a diplomat, that he should be allowed access to medication," the source said. But the source denied Indian media reports that the diplomat had been attacked by an angry crowd for defending the two businessmen on trial.
A Chinese diplomat in New Delhi said the incident would be investigated.
"I believe both governments ... will handle this properly, this seems to be a civil-civic commercial dispute," China's charge d'affaires Zhang Yue said after meeting with officials at India's foreign ministry.
"We are trying to figure out what happened," he said.
Yiwu is a small city known for manufacturing and a commodities wholesale market that attracts traders from across Asia.
Although annual bilateral trade between India and China is more than $50 billion, the neighbours have a tense diplomatic relationship linked to a brief but bloody border war in 1962 over national boundaries which remain unsettled.
(Additional reporting by Sunil Kataria; Editing by Ed Lane)
- Tweet this
- Share this
- Digg this
- Boxer Sarita Devi faces action after refusing medal at Asian Games
- Hong Kong leader plays waiting game, protesters demand he resigns
- Brookfield wins Revel Casino auction, but loser vows to fight
- CANADA STOCKS-TSX fall gets deeper as financial, energy shares drag
- UPDATE 2-EU-Russia gas duel deepens with Slovakia supply cut
India could run out of a critical medicine in its free HIV/AIDS drugs programme in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Full Article